• Date of issue: November 2016
  • Delivery: PDF

OTC market in Slovakia 2016

Market analysis and development forecasts for 2016-2021

Consult this informative report for the latest updates on and expert analysis of the current state and conditions on the OTC (over-the-counter) pharmaceuticals market in Slovakia. Study the changing regulations, new trends and new strategies of sector leaders that shape the market currently and in the near future. Monitor the data that describes market value, growth dynamics, sales totals, and 2016-2021 development forecasts in the Slovakian OTC medicines and dietary supplements sector. Follow the most up-to-date data about each of main segments: pharmacy, non-pharmacy and internet sales.
 

What is the content of PMR’s report on the OTC market in Slovakia?

 
  • Value, growth, and sales data that describe performance of the over-the-counter market and its major players in Slovakia
  • Developmental direction the market is expected to take in 2016-2021 
  • Segment analysis of pharmacy, non-pharmacy and online sales channels
  • OTC bestsellers in Slovakia
  • Top companies 
  • Switches from Rx to OTC 
  • OTC-related indices which contain for sample prices of OTC products, share of the Slovakian pharmaceutical market occupied by OTC sales, and OTC and dietary supplements market saturation 
  • Behaviour, preferences and attitudes of the OTC customers buying and using OTC products in Slovakia
  • Advertising of OTC medicines and dietary supplements, including regulations and corporate spending
  • Current and expected updates to regulations governing the market.
 
 

Who benefits from the analysis? 

 
This report was developed to support:
  • Managers / specialists in sales, strategy and marketing departments at manufacturing companies that produce OTC medicines, dietary supplements and other OTC products
  • Businesses that sell OTC products online, and in pharmacy and non-pharmacy distribution channels
  • Wholesalers and retailers as well as advertising agencies supporting them in the Slovakian OTC market
  • Importers of OTC products to Slovakia
  • Educational and research institutes, governmental offices, embassies, business consultants and analysts involved in pharmaceuticals market in Slovakia.
 

Why to buy the report? 

 
The report will allow you to benefit from a wide range of data, analyses and forecasts while:
  • Researching market conditions 
  • Evaluating prospects for growth, impact of recent events on sales of the company
  • Corporate budgeting 
  • Creating strategy 
  • Competition analysis.
 

Report updates 

 
For an additional price, PMR also offers packages that include updates of this report: “Report + 1 Update” or “Report + 2 Updates”. The above-mentioned packages are only available for purchase directly from PMR sales consultants at: sales@pmrcorporate.com / tel. +48 12 3405130.
 
The packages are dedicated to clients who need market information refreshed more often than once a year. The report and its updates are published within one year. They provide the most current data and expert commentaries. The revised indices, statistics and information will be valuable for the purposes of budgeting, strategic planning and market monitoring.
 
PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley
PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement

  • Methodology
  • Executive summary
  • Overview of the OTC market in Slovakia
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • OTC market value and volume by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2008 and 2021
      • Volume of the OTC product market
      • Value of the dietary supplement market
      • Volume of the dietary supplements market
      • OTC product market by therapeutic categories
    • Prices of OTC products
      • OTC drugs
      • Dietary supplements
    • Switch from Rx to OTC
    • Bestselling OTC products
      • By value
      • By volume
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • OTC drugs
      • Dietary supplements
      • Important events pertaining to companies present on the market
  • Profiles of selected manufacturers on the OTC market in CE
    • Bayer HealthCare
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Berlin-Chemie/Menarini
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • GlaxoSmithKline
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Krka
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Polpharma
      • General information
      • Financial results
      • Market strategy and OTC sales in CE
    • Sanofi
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Sopharma
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Teva
      • General information
      • Financial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • US Pharmacia
      • General information
      • Finacial results
      • Product portfolio
      • Market strategy and OTC sales in CE
    • Walmark
      • General information
      • Product portfolio
      • Market strategy and OTC sales in CE

Graphs

  • Number of acute respiratory infections and flu cases in Slovakia (‘000), 2009-2016
  • Number of dietary supplements in Slovakia of which launch the Public Health Authority was notified, 2010-H1 2015
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in Slovakia (%), by value, 2008, 2011, 2014-2015
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in Slovakia (%), by volume, 2008, 2011, 2014-2015
  • Share of OTC drugs as a proportion of the Slovak pharmaceutical market, retail pharmacy sales (%), by value, 2011 and 2014-2015
  • Share of OTCs as a proportion of the Slovak pharmaceutical market, retail pharmacy sales (%), by value, March 2014-February 2015 and March 2015-February 2016
  • Share of OTC drugs as a proportion of the Slovak pharmaceutical market, retail pharmacy sales (%), by volume, 2011 and 2014-2015
  • Share of OTCs as a proportion of the Slovak pharmaceutical market, retail pharmacy sales (%), by volume, March 2014-February 2015 and March 2015-February 2016
  • Value (€ m) and change (%, y-o-y) in the OTC product market in Slovakia, 2008-2020
  • Value (€ m) and change (%, y-o-y) of the dietary supplement pharmacy market in Slovakia, 2007-2021
  • Sales volume of dietary supplement pharmacy sales in Slovakia (million packets), 2007-2013 and 2015
  • Y-o-y change in the OTC product categories in Slovakia (%), by value, November 2014-October 2015
  • Estimated sales value of main dietary supplement categories in Slovakia (€ m), 2014
  • Share of drugs and dietary supplements as a proportion of the OTC product market in Slovakia (%), by categories, by value, 2014
  • Average price per OTC package in Slovakia (€), March 2014-February 2015 and March 2015-February 2016
  • Average manufacturer price per packet of dietary supplements in Slovakia (€), 2007-2015
  • Advertising spending on medicines in Slovakia (€ m) and change (%, y-o-y), 2013-2015
  • Krka Group employment breakdown (%), by regions, 2015
  • Krka's sales of OTC products in selected CE countries (€ m), 2011-2015
  • Increases in Krka's OTC sales in selected CE countries (%), H1 2016
  • Krka’s global revenues and net profit (€ m), 2005-H1 2016
  • Share of new products as a proportion of Krka’s total sales value (%), 2009-2015
  • Krka’s global revenues from OTC products (€ m) and y-o-y change (%), 2011-H1 2016
  • Share of Krka sales as a proportion of the total global market, by region (%), 2014-H1 2016
  • Krka’s sales in CE countries analysed (€ m), 2013-H1 2016
  • Krka’s global OTC sales (%), by product groups, 2015
  • Revenues and net profit of Zaklady Farmaceutyczne Polpharma SA (€ m), 2007 – Q1-Q3 2015
  • Revenues and net profit of Polpharma Biuro Handlowe Sp. z o.o. (PLN m), 2008-2014
  • Revenues and net profit of Warszawskie Zaklady Farmaceutyczne Polfa SA (PLN m), 2008 – Q1-Q3 2015
  • Revenues and net profit of Medana Pharma SA (PLN m), 2008-2014
  • Product structure for Polpharma in Poland, by number of products in specific categories (%), May 2016
  • Product structure for Polfa Warszawa in Poland, by number of products in specific categories (%), May 2016
  • Sopharma global revenues and net profit (€ m), 2008-H1 2016
  • Sopharma AD sales revenues and net profit (€ m), 2013-2015
  • Sopharma AD global revenues (€ m), by geographical market, 2013-H1 2016
  • Sopharma AD sales revenues, by country and region (%), 2014-H1 2016
  • USP Zdrowie revenue and net profit (€ m), 2011-2014
  • US Pharmacia revenue and net profit (€ m), 2009-2014
  • Product structure for USP Zdrowie/US Pharmacia in Poland, by number of products in specific categories (%), May 2016
  • Walmark sales revenues in Poland (€ m) and change (%, y-o-y), 2008/2009-2014/2015
  • Walmark sales revenues in Hungary (€ m) and change (%, y-o-y), 2009/2010-2014/2015
  • Walmark’s sales revenues in Romania (€ m) and change (%, y-o-y), 2010-2015
  • Walmark a.s. revenues (€ m) and change (%, y-o-y), 2011/2012-2014/2015
  • Walmark sales revenues in Bulgaria (€ m) and change (%, y-o-y), 2008-2014
  • Walmark sales revenues in Slovakia (€ m) and change (%, y-o-y), 2010/2011-2014/2015

Tables

  • Main past trends and events, and their effects on the OTC market in Slovakia, 2014-2016
  • Percentage of people vaccinated against flu in Slovakia (%), 2004/2005-2015/2016
  • Share of OTC drugs and dietary supplements as a proportion of sales value of pharmacies in Slovakia (%), by category of pharmacy, November 2014-October 2015
  • Market share of individual and chain pharmacies as a proportion of the OTC product market in Slovakia (%), by value, March 2013-February 2016
  • Estimated share of OTC drugs and dietary supplements as a proportion of sales value of selected pharmacy chains and alliances in Slovakia (%), January 2016
  • Number of packets of OTCs sold in Slovakia (million) and change (%), March 2015-February 2016
  • Consumption of reimbursed dietary supplements in Slovakia, 2012-2015
  • OTC product market in Slovakia, by main product categories (€ m), 2012-2021
  • OTC drug pharmacy market in Slovakia, by main ATC categories (%), by value, 2013-2015
  • Sales value of OTC drugs in Slovakia, by main ATC categories (€ m) and y-o-y change (%), 2013-2015
  • OTC drug pharmacy market in Slovakia, by main ATC categories (%), by volume, 2013-2015
  • Sales volume of OTC drug categories in Slovakia, by main ATC categories (million packets) and y-o-y change (%), 2013-2015
  • Sales value (€) and volume ('000) of OTC drugs in Slovakia, by 2-level ATC categories, 2015
  • Sales value, volume and shares of homeopathic OTC drugs in Slovakia, 2014-2015
  • Market share of main dietary supplement categories in Slovakia (%), by value, 2014
  • Average price per packet of OTC drugs in Slovakia (€), by ATC category, 2013-2015
  • Average prices per packet of selected bestselling OTC drugs in Slovakia (€), 2015
  • Rx-to-OTC switches in Slovakia, 2015-September 2016
  • Selected 10 bestselling OTC drugs in Slovakia, by value (€ m), 2015
  • 25 bestselling OTC drugs in Slovakia, by volume ('000), 2015
  • OTC products most commonly recommended by pharmacists in Slovakia in selected product categories (%), 2015
  • Data on SUKL activity in the area of drug advertising in Slovakia, 2007-2015
  • Top 10 manufacturers of OTC drugs in Slovakia, by value (€ m), at manufacturer prices, 2010-H1 2016
  • Top 10 manufacturers of OTC drugs in Slovakia, by volume (’000), 2010-H1 2016
  • Sales revenues (€ m) and change (%, y-o-y) of selected leading dietary supplement manufacturers in Slovakia, 2013-2015
  • General information pertaining to Bayer HealthCare, 2016
  • Companies belonging to Bayer in CE countries analysed, 2016
  • Sales of individual Bayer companies registered in selected CE countries (€ m), 2015
  • General information pertaining to Bayer’s product portfolio, 2015
  • General information pertaining to Berlin-Chemie/Menarini, 2015
  • Sales of individual Berlin-Chemie/Menarini companies registered in selected CE countries (€ m), 2015
  • General information pertaining to Berlin-Chemie/Menarini’s product portfolio, 2016
  • General information pertaining to GlaxoSmithKline, 2016
  • Companies belonging to GSK in CE countries analysed, 2016
  • Sales of individual GSK companies registered in selected CE countries (€ m), 2013, 2014 or 2015
  • General information pertaining to GSK’s product portfolio, 2016
  • Selected GSK’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • General information pertaining to Krka, 2016
  • Ownership structure of Krka (%), 2016
  • Companies belonging to Krka in CE countries analysed, 2016
  • Structure of Krka in CE countries analysed, 2015
  • Sales of individual Krka companies registered in selected CE countries (€ m), 2013 or 2015
  • Krka’s sales breakdown, by product or category of service (€ m) and change (y-o-y, %), 2014-H1 2016
  • Krka’s global sales (€ m), by region, 2012-H1 2016
  • General information pertaining to Krka’s product portfolio in CE countries analysed, H1 2016
  • General information pertaining to sales of Krka OTC products in Poland, 2015-H1 2016
  • General information pertaining to sales of Krka OTC products in Hungary, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in Romania, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in the Czech Republic, 2015-H1 2016
  • General information pertaining to sales of Krka’s OTC products in Bulgaria, 2015
  • General information pertaining to sales of Krka’s OTC products in Slovakia, 2015-H1 2015
  • General information about Polpharma Group in Poland, 2016
  • Ownership structure of Polpharma Group in Poland, 2016
  • Selected Polpharma’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • Polpharma Group’s planned and ongoing investments in its facilities in Poland, 2016
  • General information pertaining to Sanofi, 2016
  • Companies belonging to Sanofi in CE countries analysed, 2016
  • Sales of individual Sanofi companies registered in selected CE countries (€ m), 2014 or 2015
  • General information pertaining to Sanofi’s product portfolio, 2015
  • General information pertaining to Sopharma, Q1 2016
  • Ownership structure of Sopharma AD (%), 30 June 2016
  • Selected companies in Sopharma Group in CE countries analysed, Q2 2016
  • Total area (m²), capacity and number of employees at selected Sopharma manufacturing plants in Bulgaria, 2015
  • Sopharma Group sales revenues from goods, by pharmaceutical form (%), H1 2016
  • Sopharma Group sales revenues from finished products, by pharmaceutical form (%), H1 2016
  • General information pertaining to Sopharma product portfolio, 2014
  • General information pertaining to Teva, 2016
  • Sales of individual Teva companies registered in selected CE countries (€ m), 2014 or 2015
  • General information pertaining to Teva’s product portfolio, 2015
  • General information pertaining to US Pharmacia/USP Zdrowie, 2016
  • Ownership structure of USP Zdrowie in Poland (%), 2016
  • General information pertaining to USP Zdrowie product portfolio, 2016
  • Selected USP Zdrowie’s OTC products with the highest advertising spending in Poland (PLN m), January-May 2016
  • General information pertaining to Walmark, 2016
  • Ownership structure of Walmark (%), 2016
  • Structure of Walmark in CE countries analysed, 2016
  • General information pertaining to Walmark’s product portfolio, 2014
  • Leading Walmark’s dietary supplement brands in Central Europe, 2015
  • General information pertaining to sales of Walmark OTC products in Poland, October 2016
  • General information pertaining to sales of Walmark OTC products in Hungary, October 2016
  • General information pertaining to sales of Walmark’s OTC products in Romania, 2016
  • General information pertaining to sales of Walmark OTC products in the Czech Republic, 2016
  • General information pertaining to sales of Walmark OTC products in Bulgaria, 2015
  • General information pertaining to sales of Walmark OTC products in Slovakia, 2016